All blog posts
Total 246 results for
Showing 120 out of 246 results
06 7月 2021
NHS fails in appeal on 'unlawful means tort' in claim for damages allegedly caused by Servier's actions in delaying generic market entry
24 6月 2021
Federal Court overturns ‘absurd’ Patent Office ruling on patent term extensions for pharmaceutical substances
09 6月 2021
UK IPO Consultation on the UK's future exhaustion of IP rights regime
14 5月 2021
Emma and Rebekah Talk IP: COVID-19 vaccines and patent waiver rights
28 4月 2021
Pharmaceutical patent term extensions: federal court hears challenge to “absurd” Australian patent office ruling
30 3月 2021
EU Action Plan on IP – the challenge ahead
23 3月 2021
Judicial review - another weapon in Big Pharma's disputes arsenal?
11 3月 2021
A ‘new normal’ when it comes to the TGA regulation of medical devices?
09 3月 2021
Patent pending: the law on AI inventorship
05 3月 2021
First time EU Commission pursues case relating to divisional patent filing and litigation strategies
02 3月 2021
UK Government publishes revised sector definitions for mandatory notification under new national security screening regime
16 2月 2021
Patent and Pharma Update, February 2021
Showing 120 out of 246 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London